Close Menu

NEW YORK (GenomeWeb) – Chinese firm MedCDx and US-based Admera Health said today that they have entered a non-exclusive collaboration agreement to gain access to each other's existing portfolios and codevelop new companion diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.